Table 9.
Mean serum liver function markers at baseline (week 0), week 4 and 8 between intervention groups.
| PL | dGTE | dGTE+ | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Variable | Baseline | Week 4 | Week 8 | Baseline | Week 4 | Week 8 | Baseline | Week 4 | Week 8 |
| ALT (U·L−1) | 56.89 ± 23.14 | 47.22 ± 15.86 | 40.67 ± 11.72 | 34.56 ± 2.69 | 28.89 ± 1.62 | 34.22 ± 2.41 | 28.33 ± 1.41 | 30.78 ± 1.82 | 31.33 ± 1.85 |
| AST (U·L−1) | 28.33 ± 10.70 | 37.11 ± 15.58 | 20.11 ± 3.51 | 19.78 ± 1.23 | 17.11 ± 1.62 | 21.11 ± 1.35 | 19.11 ± 2.12 | 18.22 ± 1.42 | 19.33 ± 1.27 |
| ALP (U·L−1) | 66.89 ± 7.13 * | 65.22 ± 5.96 * | 60.22 ± 6.15 | 60.11 ± 3.36 | 60.00 ± 3.76 | 59.00 ± 4.20 | 59.44 ± 3.70 | 60.67 ± 4.18 | 56.67 ± 3.82 |
| Bilirubin (µmol·L−1) | 10.78 ± 2.26 | 9.33 ± 1.80 | 9.89 ± 1.14 | 9.67 ± 0.94 | 9.89 ± 0.92 | 10.00 ± 1.04 | 7.78 ± 0.81 | 7.56 ± 0.87 | 8.44 ± 0.67 |
PL = placebo; dGTE = decaffeinated green tea extract; dGTE+ = decaffeinated green tea extract with antioxidants. ALT = alanine aminotransferase; AST = aspartate transaminase; ALP = alkaline phosphatase. * significantly different to week 8 within group (p ≤ 0.025).